Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2011 Dec;22(12):2160-70.
doi: 10.1007/s13361-011-0240-7. Epub 2011 Oct 5.

Structural definition of trehalose 6-monomycolates and trehalose 6,6'-dimycolates from the pathogen Rhodococcus equi by multiple-stage linear ion-trap mass spectrometry with electrospray ionization

Affiliations

Structural definition of trehalose 6-monomycolates and trehalose 6,6'-dimycolates from the pathogen Rhodococcus equi by multiple-stage linear ion-trap mass spectrometry with electrospray ionization

Fong-Fu Hsu et al. J Am Soc Mass Spectrom. 2011 Dec.

Abstract

The cell wall of the pathogenic bacterium Rhodococcus equi (R. equi) contains abundant trehalose monomycolate (TMM) and trehalose dimycolate (TDM), the glycolipids bearing mycolic acids. Here, we describe multiple-stage (MS(n)) linear ion-trap (LIT) mass spectrometric approaches toward structural characterization of TMM and TDM desorbed as [M + Alk](+) (Alk = Na, Li) and as [M + X](-) (X = CH(3)CO(2), HCO(2)) ions by electrospray ionization (ESI). Upon MS(n) (n=2, 3, 4) on the [M + Alk](+) or the [M + X](-) adduct ions of TMM and TDM, abundant structurally informative fragment ions are readily available, permitting fast assignment of the length of the meromycolate chain and of the α-branch on the mycolyl residues. In this way, structures of TMM and TDM isolated from pathogenic R. equi strain 103 can be determined. Our results indicate that the major TMM and TDM molecules possess 6, and/or 6'-mycolyl groups that consist of mainly C14 and C16 α-branches with meromycolate branches ranging from C18 to C28, similar to the structures of the unbound mycolic acids found in the cell envelope. Up to 60 isobaric isomers varying in chain length of the α-branch and of the meromycolate backbone were observed for some of the TDM species in the mixture. This mass spectrometric approach provides a direct method that affords identification of various TMM and TDM isomers in a mixture of which the complexity of this lipid class has not been previously reported using other analytical methods.

PubMed Disclaimer

Figures

Figure 1
Figure 1
The ESI-MS spectra of the [M + Na]+ ions of TMM (a) and of TDM (b). These profiles are similar to their [M + CH3CO2] adduct ions (see supplemental material Figure S1).
Figure 2
Figure 2
The LIT MS2 spectrum of the [M + Na]+ ion of TMM at m/z 871 (a), its MS3 spectra at m/z 603 (871 → 603) (b), and at m/z 709 (871 → 709) (c).
Figure 3
Figure 3
The LIT MS2 spectrum of the [M + Na]+ ion of TDM at m/z 1378 (a), its MS3 spectra at m/z 1109 (1378 → 1109) (b), its MS4 spectra at m/z 813 (1378 → 1109 → 813) (c), and at m/z 737 (1378 → 1109 → 737) (d); the MS3 spectra of the ions of m/z 1081 (1378 → 1081) (e), and of m/z 1053 (1378 → 1053) (f)
Figure 4
Figure 4
The LIT MS2 spectra of the [M + CH3CO2]- ion of TMM at m/z 907 (a), its MS3 spectra at m/z 829 (907 → 829) (b), and at m/z 579 (907 → 579) (c).
Scheme 1
Scheme 1
The fragmenation pathways proposed for the [M + Na]+ ions of 6-mycolyl-α,α'-D-trehalose (TMM) (the indicated m/z values are ions seen for18:0/16:0-TMM, which is one of the 3 isomers that give rise to the [M+Na]+ of m/z 871)
Scheme 2
Scheme 2
The fragmentation tree applying multiple-stage mass spectrometry (MSn) for structural assignment of the [M + Na]+ ions of 6,6'-dimycolyl-α,α'-D-trehalose (TDM).
Scheme 3
Scheme 3
The fragmentation pathways proposed for the [M + Na]+ ions of 6,6'-dimycolyl-α,α'-D-trehalose (TDM). The indicated m/z values are fragment ions seen for (20:0/14:0-18:0/16:0-TDM isomer, which is one of the major isomers that represent the sodiated molecular species of m/z 1378.1

Similar articles

Cited by

References

    1. Giguère S, Prescott JF. Clinical Manifestations, Diagnosis, Treatment and Prevention of Rhodococcus Equi Infections in Foals. Vet. Microbiol. 1997;56:313–334. - PubMed
    1. Prescott JF. Rhodococcus Equi: An Animal and Human Pathogen. Clin Microbiol Rev. 1991;4:20–34. - PMC - PubMed
    1. von Bargen K, Haas A. Molecular and Infection Biology of the Horse Pathogen Rhodococcus Equi. FEMS Microbiol Rev. 2009;33:870–891. - PubMed
    1. Sutcliffe IC. Cell Envelope Composition and Organisation in the Genus Rhodococcus. Antonie van Leeuwenhoek. 1998;74:49–58. - PubMed
    1. Sutcliffe I, Brown A, Dover L. The Rhodococcal Cell Envelope: Composition, Organisation and Biosynthesis. Journal. 2010;16:29–71.

Publication types